Cargando…

Clinical Impact of Pitolisant on Excessive Daytime Sleepiness and Cataplexy in Adults With Narcolepsy: An Analysis of Randomized Placebo-Controlled Trials

BACKGROUND: Pitolisant, a selective histamine 3 receptor antagonist/inverse agonist, is indicated for the treatment of excessive daytime sleepiness or cataplexy in adults with narcolepsy. The efficacy and safety of pitolisant have been demonstrated in randomized placebo-controlled trials. When evalu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meskill, Gerard J., Davis, Craig W., Zarycranski, Donna, Doliba, Markiyan, Schwartz, Jean-Charles, Dayno, Jeffrey M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8732895/ https://www.ncbi.nlm.nih.gov/pubmed/34935103 http://dx.doi.org/10.1007/s40263-021-00886-x

Ejemplares similares

Time to Onset of Response to Pitolisant for the Treatment of Excessive Daytime Sleepiness and Cataplexy in Patients With Narcolepsy: An Analysis of Randomized, Placebo-Controlled Trials
por: Watson, Nathaniel F., et al.
Publicado: (2021)

Pitolisant to Treat Excessive Daytime Sleepiness and Cataplexy in Adults with Narcolepsy: Rationale and Clinical Utility
por: Guevarra, Jay T, et al.
Publicado: (2020)

Evaluation of the abuse potential of pitolisant, a selective H(3)-receptor antagonist/inverse agonist, for the treatment of adult patients with narcolepsy with or without cataplexy
por: Setnik, Beatrice, et al.
Publicado: (2019)

Calcium, Magnesium, Potassium, and Sodium Oxybates Oral Solution: A Lower-Sodium Alternative for Cataplexy or Excessive Daytime Sleepiness Associated with Narcolepsy
por: Dauvilliers, Yves, et al.
Publicado: (2022)

Lisdexamfetamine to improve excessive daytime sleepiness and weight management in narcolepsy: a case series
por: Aguilar, Ana C., et al.
Publicado: (2019)

Update on the treatment of narcolepsy: clinical efficacy of pitolisant
por: Calik, Michael W
Publicado: (2017)

Narcolepsy with cataplexy in monozygotic twins
por: Goulart, Leonardo I., et al.
Publicado: (2014)

Pharmacological Interventions for Excessive Daytime Sleepiness in Adults with Narcolepsy: A Systematic Review and Network Meta-Analysis
por: Chien, Po-Yu, et al.
Publicado: (2022)

Efficacy of Pitolisant on the Treatment of Narcolepsy: A Systematic Review
por: Fabara, Stephanie P, et al.
Publicado: (2021)

Efficacy of Pitolisant 20 mg in Reducing Excessive Daytime Sleepiness and Fatigue in Patients with Obstructive Sleep Apnoea Syndrome: An Individual Patient Data Meta-analysis
por: Lehert, Philippe
Publicado: (2021)

Low Vitamin D in Narcolepsy with Cataplexy
por: Carlander, Bertrand, et al.
Publicado: (2011)

Baclofen for narcolepsy with cataplexy: two cases
por: Lee, Elliott Kyung, et al.
Publicado: (2015)

Excessive Daytime Sleepiness in Parkinson’s Disease
por: Liu, Hanshu, et al.
Publicado: (2022)

Circadian rhythm of daytime sleepiness in pediatric narcolepsy: A pilot study
por: Ouyang, Hui, et al.
Publicado: (2023)

Profile of pitolisant in the management of narcolepsy: design, development, and place in therapy
por: Romigi, Andrea, et al.
Publicado: (2018)

Psychomotor Vigilance Performance in Participants with Excessive Daytime Sleepiness in Obstructive Sleep Apnea or Narcolepsy Compared with SAFTE-FAST Model Predictions
por: Devine, Jaime K., et al.
Publicado: (2022)

Pitolisant for Daytime Sleepiness in Patients with Obstructive Sleep Apnea Who Refuse Continuous Positive Airway Pressure Treatment. A Randomized Trial
por: Dauvilliers, Yves, et al.
Publicado: (2020)

Long-term use of pitolisant to treat patients with narcolepsy: Harmony III Study
por: Dauvilliers, Yves, et al.
Publicado: (2019)

A randomized study of solriamfetol for excessive sleepiness in narcolepsy
por: Thorpy, Michael J., et al.
Publicado: (2019)

Profile of Solriamfetol in the Management of Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea: Focus on Patient Selection and Perspectives
por: Abad, Vivien C
Publicado: (2021)

Examining the impact of excessive daytime sleepiness on utility scores in patients with obstructive sleep apnoea and/or narcolepsy in five European countries
por: Cambron-Mellott, M. Janelle, et al.
Publicado: (2022)

Clinical and polysomnographic course of childhood narcolepsy with cataplexy
por: Pizza, Fabio, et al.
Publicado: (2013)

Treatment cost of narcolepsy with cataplexy in Central Europe
por: Maresova, Petra, et al.
Publicado: (2016)

Assessing narcolepsy with cataplexy in children and adolescents: development of a cataplexy diary and the ESS-CHAD
por: Wang, Y Grace, et al.
Publicado: (2017)

Excessive daytime sleepiness among depressed patients
por: Mume, Celestine Okorome
Publicado: (2010)

Internet addiction and excessive daytime sleepiness in adolescents
por: Semenova, N., et al.
Publicado: (2021)

Treat the Symptom, Not the Cause? Pitolisant for Sleepiness in Obstructive Sleep Apnea
por: Trotti, Lynn Marie
Publicado: (2020)

The use of an online Epworth Sleepiness Scale to assess excessive daytime sleepiness
por: Boyes, Jennifer, et al.
Publicado: (2016)

Orgasmolepsy in Narcolepsy Type 1 Responsive to Pitolisant: A Case Report
por: Pellitteri, Gaia, et al.
Publicado: (2020)

Comparative Efficacy and Safety of Multiple Wake-Promoting Agents for the Treatment of Excessive Daytime Sleepiness in Narcolepsy: A Network Meta-Analysis
por: Zhan, Shuqin, et al.
Publicado: (2023)

Non-Dipping Blood Pressure Profile in Narcolepsy with Cataplexy
por: Dauvilliers, Yves, et al.
Publicado: (2012)

Treatment paradigms for cataplexy in narcolepsy: past, present, and future
por: Swick, Todd J
Publicado: (2015)

Pituitary Macrotumor Causing Narcolepsy‐Cataplexy in a Dachshund
por: Schmid, S., et al.
Publicado: (2017)

Striatal dopamine regulates sleep states and narcolepsy-cataplexy
por: Toth, Brandon A., et al.
Publicado: (2023)

Epigenetic silencing of selected hypothalamic neuropeptides in narcolepsy with cataplexy
por: Seifinejad, Ali, et al.
Publicado: (2023)

Determinants of excessive daytime sleepiness in two First Nation communities
por: van der Spuy, Ina, et al.
Publicado: (2017)

Excessive Daytime Sleepiness and Epilepsy: A Systematic Review
por: Giorelli, Andre S., et al.
Publicado: (2013)

Cancer-related fatigue presenting with excessive daytime sleepiness
por: Balachandran, Diwakar D, et al.
Publicado: (2017)

Excessive daytime sleepiness in adolescents: current treatment strategies
por: Hein, Matthieu, et al.
Publicado: (2020)

Evaluation and Treatment of Children and Adolescents With Excessive Daytime Sleepiness
por: Owens, Judith A., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_s0ovo1k50g9vdddtdn5f7iriei